Josef Finsterer, MD, PhD*, Marlies Frank, MD. (2020). Evidence level for effectiveness of glucagon-like peptide-1 receptor agonists respectively sodium glucose co-transporter-2 inhibitors for mitochondrial diabetes is low. Innovative Journal of Medical and Health Sciences, 10(06), 959–960. Retrieved from https://innovativejournal.in/index.php/ijmhs/article/view/2988